Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extensionKarine Briot, Erik A. Imel, Suzanne M. Jan de Beur et al.|RMD Open|2021Cited by 72
Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesityMark Nixon, Rebecca Berdeaux, Eric D. Berglund et al.|Molecular Metabolism|2015Cited by 57